Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69 | HIV Clinical Trials | journal | 0.899 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
68 | Klinik Psikofarmakoloji Bulteni | journal | 0.193 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
67 | npj Vaccines | journal | 47 | 16 | 0 | 687 | 0 | 0 | 0.00 | 42.94 | 40.00 | ||
66 | Prescriber | journal | 0.126 Q4 | 4 | 16 | 8 | 265 | 1 | 6 | 0.13 | 16.56 | 44.00 | |
65 | Therapeutic Advances in Vaccines | journal | 1.810 Q1 | 5 | 0 | 6 | 0 | 62 | 6 | 10.33 | 0.00 | 0.00 | |
64 | Journal of Prescribing Practice | journal | 2 | 2 | 8 | 52 | 3 | 8 | 0.38 | 26.00 | 33.33 | ||
63 | npj Breast Cancer | journal | 46 | 26 | 14 | 1105 | 16 | 12 | 1.14 | 42.50 | 55.23 | ||
62 | PharmacoEconomics - Italian Research Articles | journal | 0.123 Q4 | 9 | 0 | 16 | 0 | 2 | 16 | 0.20 | 0.00 | 0.00 | |
61 | Molecular Therapy - Oncolytics | journal | 0.452 Q3 | 42 | 38 | 28 | 1858 | 39 | 27 | 1.39 | 48.89 | 33.33 | |
60 | Journal of Pharmaceutical Health Care and Sciences | journal | 10 | 2 | 29 | 29 | 17 | 28 | 0.59 | 14.50 | 0.00 | ||
59 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 40 | 39 | 49 | 1560 | 94 | 32 | 1.92 | 40.00 | 20.37 | ||
58 | Pharmaceutical Medicine | journal | 0.205 Q3 | 25 | 30 | 61 | 865 | 35 | 48 | 0.60 | 28.83 | 40.45 | |
57 | Therapeutic Advances in Drug Safety | journal | 1.702 Q1 | 46 | 27 | 67 | 869 | 331 | 55 | 5.80 | 32.19 | 55.38 | |
56 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 26 | 69 | 1367 | 180 | 69 | 2.16 | 52.58 | 39.58 | ||
55 | Therapeutic Advances in Respiratory Disease | journal | 0.955 Q2 | 50 | 48 | 82 | 2539 | 230 | 74 | 2.98 | 52.90 | 31.09 | |
54 | Therapeutic Advances in Cardiovascular Disease | journal | 0.500 Q3 | 41 | 36 | 101 | 1309 | 154 | 87 | 1.52 | 36.36 | 26.53 | |
53 | HIV Research and Clinical Practice | journal | 54 | 31 | 90 | 1118 | 178 | 89 | 1.80 | 36.06 | 46.62 | ||
52 | AIDS Research and Therapy | journal | 1.010 Q2 | 49 | 41 | 115 | 1960 | 262 | 113 | 1.89 | 47.80 | 39.09 | |
51 | Clinical Pharmacist | journal | 0.101 Q4 | 11 | 153 | 137 | 2173 | 7 | 114 | 0.05 | 14.20 | 58.97 | |
50 | Antimicrobial Resistance and Infection Control | journal | 1.182 Q1 | 66 | 56 | 127 | 1944 | 414 | 119 | 3.04 | 34.71 | 46.93 | |
49 | American Journal of Cardiovascular Drugs | journal | 0.927 Q2 | 60 | 44 | 129 | 2322 | 358 | 121 | 2.98 | 52.77 | 25.58 | |
48 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | 34.85 | |
47 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | 45.00 | |
46 | Paediatric Drugs | journal | 0.986 Q2 | 70 | 44 | 147 | 2433 | 407 | 139 | 2.56 | 55.30 | 55.25 | |
45 | Clinical Practice | journal | 0.137 Q4 | 10 | 13 | 163 | 345 | 38 | 142 | 0.34 | 26.54 | 38.24 | |
44 | Psychiatry and Clinical Psychopharmacology | journal | 24 | 71 | 172 | 1872 | 69 | 143 | 0.41 | 26.37 | 38.70 | ||
43 | Biopharmaceutics and Drug Disposition | journal | 0.681 Q2 | 65 | 48 | 147 | 1600 | 385 | 144 | 2.17 | 33.33 | 36.47 | |
42 | Pharmaceutical Statistics | journal | 1.004 Q2 | 46 | 55 | 152 | 1667 | 195 | 145 | 1.22 | 30.31 | 23.57 | |
41 | Cardiovascular Therapeutics | journal | 1.095 Q1 | 54 | 58 | 168 | 2165 | 424 | 161 | 2.53 | 37.33 | 31.96 | |
40 | European Journal of Contraception and Reproductive Health Care | journal | 0.683 Q2 | 53 | 71 | 176 | 2129 | 280 | 165 | 1.60 | 29.99 | 62.97 | |
39 | Journal of Chemotherapy | journal | 0.521 Q3 | 56 | 88 | 199 | 2535 | 278 | 176 | 1.27 | 28.81 | 44.42 | |
38 | BMC pharmacology & toxicology | journal | 0.940 Q2 | 43 | 62 | 180 | 2499 | 525 | 177 | 2.81 | 40.31 | 37.34 | |
37 | Drug and Therapeutics Bulletin | journal | 0.119 Q4 | 17 | 140 | 418 | 1007 | 28 | 177 | 0.07 | 7.19 | 0.00 | |
36 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.127 Q1 | 57 | 59 | 184 | 2833 | 510 | 179 | 2.95 | 48.02 | 24.87 | |
35 | Journal of Oncology Pharmacy Practice | journal | 0.546 Q3 | 44 | 124 | 205 | 2939 | 310 | 192 | 1.56 | 23.70 | 48.66 | |
34 | Human Psychopharmacology | journal | 1.018 Q2 | 86 | 46 | 203 | 2208 | 570 | 201 | 2.58 | 48.00 | 42.64 | |
33 | Expert Review of Clinical Pharmacology | journal | 1.040 Q2 | 60 | 156 | 228 | 11087 | 661 | 208 | 2.84 | 71.07 | 39.29 | |
32 | Fundamental and Clinical Pharmacology | journal | 0.840 Q2 | 85 | 64 | 212 | 2749 | 548 | 211 | 2.45 | 42.95 | 46.58 | |
31 | Drugs and Therapy Perspectives | journal | 0.117 Q4 | 13 | 81 | 216 | 2293 | 22 | 215 | 0.10 | 28.31 | 63.37 | |
30 | Clinical Pharmacokinetics | journal | 1.599 Q1 | 184 | 110 | 269 | 6748 | 1381 | 244 | 4.68 | 61.35 | 41.99 | |
29 | CNS Drugs | journal | 1.819 Q1 | 129 | 89 | 269 | 7703 | 1484 | 257 | 5.12 | 86.55 | 38.40 | |
28 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.707 Q2 | 61 | 86 | 273 | 4051 | 480 | 266 | 1.61 | 47.10 | 41.97 | |
27 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | 40.10 | |
26 | Drugs and Aging | journal | 1.263 Q1 | 109 | 88 | 280 | 5141 | 1023 | 273 | 3.23 | 58.42 | 41.88 | |
25 | HIV Medicine | journal | 1.624 Q1 | 86 | 89 | 302 | 4147 | 900 | 280 | 2.78 | 46.60 | 43.01 | |
24 | Journal of Biomedical Science | journal | 1.221 Q1 | 110 | 88 | 298 | 5452 | 947 | 298 | 3.09 | 61.95 | 37.61 | |
23 | CNS Neuroscience and Therapeutics | journal | 1.567 Q1 | 91 | 128 | 425 | 6031 | 1514 | 324 | 3.34 | 47.12 | 43.92 | |
22 | Clinical Drug Investigation | journal | 0.592 Q2 | 67 | 104 | 342 | 3923 | 654 | 326 | 2.08 | 37.72 | 39.68 | |
21 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.669 Q2 | 81 | 123 | 332 | 3406 | 700 | 330 | 1.94 | 27.69 | 48.64 | |
20 | Antiviral Therapy | journal | 1.247 Q1 | 93 | 96 | 349 | 2850 | 877 | 339 | 2.34 | 29.69 | 45.02 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®